Nicotrol

Nicotrol is a specialized brand of nicotine replacement therapy (NRT) products currently owned and marketed by Pfizer. The brand encompasses a range of smoking cessation aids, most notably the Nicotrol Inhaler and Nicotrol NS nasal spray, which are available by prescription. These products are designed to alleviate nicotine withdrawal symptoms by delivering therapeutic doses of nicotine through the oral or nasal mucosa. As a key player in the smoking cessation market, Nicotrol provides healthcare providers and patients with clinically proven alternatives to combustible tobacco. The brand was originally developed by Pharmacia & Upjohn before becoming part of the Pfizer portfolio through corporate acquisitions. Nicotrol remains a standard-of-care option for intensive tobacco cessation programs worldwide.